Health Catalyst
HCAT
185 hedge funds and large institutions have $1.39B invested in Health Catalyst in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 84 increasing their positions, 44 reducing their positions, and 33 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 44
16% more call options, than puts
Call options by funds: $1.96M | Put options by funds: $1.69M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less funds holding
Funds holding: 186 → 185 (-1)
3% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 33
6.16% less ownership
Funds ownership: 106.02% → 99.85% (-6.2%)
36% less capital invested
Capital invested by funds: $2.18B → $1.39B (-$794M)
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$20.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.9M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$9.79M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$7.87M |
| 5 |
DG
Daventry Group
New York
|
+$7.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$127M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$14M |
| 3 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
-$9.71M |
| 4 |
SG Americas Securities
New York
|
-$9.57M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$7.95M |
HCAT Hedge Fund Activity: Q1 2022 in Review
185 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q1 2022, worth a combined $1.39B — down 36% from $2.18B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of HCAT and 32 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 84 added.
The largest buyer was AllianceBernstein, adding an estimated $20.2M. The largest seller was Fidelity Investments, cutting an estimated $127M.
- 185 institutional investors held Health Catalyst (HCAT) as of Q1 2022, down from 186 in Q4 2021.
- Funds reported $1.39B of Health Catalyst stock for Q1 2022, down 36% quarter-over-quarter.
- 32 funds opened new Health Catalyst positions in Q1 2022 and 33 closed out, a net change of -1 holder.
- The largest Health Catalyst buyer in Q1 2022 was AllianceBernstein, an estimated $20.2M added.
- The largest Health Catalyst seller in Q1 2022 was Fidelity Investments, an estimated $127M sold.
Based on aggregated 13F filings for Q1 2022.